Literature DB >> 9266386

Mitochondrial abnormalities of liver in two children with citrullinaemia.

S A Zamora1, A Pinto, R B Scott, H G Parsons.   

Abstract

Citrullinaemia is a rare inborn error of urea-cycle metabolism. Two affected children are reported in whom progressive metabolic instability suggested the possibility of hepatopathy or an ongoing hepatic mitochondrial injury. A percutaneous liver biopsy was performed in each patient. Electron-microscopic findings were similar in both cases. Approximately 20% of the mitochondria were abnormally enlarged with paracrystalline inclusions and electron-dense bodies of different sizes and shapes present in the matrix. The specificity of these findings is discussed in the context of previous reports of ultrastructural abnormalities in the hepatocytes of patients with inborn errors of the urea cycle. It is speculated that the mitochondrial abnormalities in citrullinaemia may be related to the accumulation of citrulline in the mitochondria which may eventually manifest as metabolic instability.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9266386     DOI: 10.1023/a:1005341228486

Source DB:  PubMed          Journal:  J Inherit Metab Dis        ISSN: 0141-8955            Impact factor:   4.982


  17 in total

1.  Heritable urea cycle enzyme deficiency-liver disease in 16 patients.

Authors:  D R LaBrecque; P S Latham; C A Riely; Y E Hsia; G Klatskin
Journal:  J Pediatr       Date:  1979-04       Impact factor: 4.406

2.  Transport of ornithine and citrulline across the mitochondrial membrane.

Authors:  J G Gamble; A L Lehninger
Journal:  J Biol Chem       Date:  1973-01-25       Impact factor: 5.157

3.  Variants of citrullinaemia.

Authors:  H Wick; C Bachmann; R Baumgartner; T Brechbühler; J P Colombo; U Wiesmann; M J Mihatsch; H Ohnacker
Journal:  Arch Dis Child       Date:  1973-08       Impact factor: 3.791

4.  Hepatic stimulator substance protects against acute liver failure induced by carbon tetrachloride poisoning in mice.

Authors:  M H Mei; W An; B H Zhang; Q Shao; D Z Gong
Journal:  Hepatology       Date:  1993-04       Impact factor: 17.425

5.  Mitochondrial abnormalities of liver in primary ornithine transcarbamylase deficiency.

Authors:  J M Shapiro; F Schaffner; H H Tallan; G E Gaull
Journal:  Pediatr Res       Date:  1980-05       Impact factor: 3.756

6.  Evidence for the existence of an ornithine/citrulline antiporter in rat liver mitochondria.

Authors:  N M Bradford; J D McGivan
Journal:  FEBS Lett       Date:  1980-05-05       Impact factor: 4.124

7.  Identification and purification of the ornithine/citrulline carrier from rat liver mitochondria.

Authors:  C Indiveri; A Tonazzi; F Palmieri
Journal:  Eur J Biochem       Date:  1992-07-15

8.  Effects of urease-induced hyperammonemia in mouse liver. Ultrastructural, stereologic and biochemical study.

Authors:  J E O'Connor; J Renau-Piqueras; S Grisolía
Journal:  Virchows Arch B Cell Pathol Incl Mol Pathol       Date:  1984

9.  Liver ultrastructure in mitochondrial urea cycle enzyme deficiencies and comparison with Reye's syndrome.

Authors:  P S Latham; D R LaBrecque; J W McReynolds; G Klatskin
Journal:  Hepatology       Date:  1984 May-Jun       Impact factor: 17.425

10.  Kinetic characterization of the reconstituted ornithine carrier from rat liver mitochondria.

Authors:  C Indiveri; L Palmieri; F Palmieri
Journal:  Biochim Biophys Acta       Date:  1994-12-30
View more
  2 in total

1.  Metabolic investigations prevent liver transplantation in two young children with citrullinemia type I.

Authors:  Martijn J de Groot; Marcel Cuppen; Marc Eling; Frans W Verheijen; Edmond H H M Rings; Dirk-Jan Reijngoud; Maaike M C de Vries; Francjan J van Spronsen
Journal:  J Inherit Metab Dis       Date:  2010-09-18       Impact factor: 4.982

2.  Metabolically based liver damage pathophysiology in patients with urea cycle disorders - A new hypothesis.

Authors:  Ivan Ivanovski; Miloš Ješić; Ana Ivanovski; Livia Garavelli; Petar Ivanovski
Journal:  World J Gastroenterol       Date:  2017-11-28       Impact factor: 5.742

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.